Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AstraZeneca Says Prilosec OTC Sales “Flattish” In The First Quarter

This article was originally published in The Tan Sheet

Executive Summary

Sales of Procter & Gamble's Prilosec OTC leveled off in the first quarter compared to the three months of its initial launch last year, according to AstraZeneca
Advertisement

Related Content

P&G Builds Heartburn Market Lead, Continues Focus On Whitening Products
P&G Builds Heartburn Market Lead, Continues Focus On Whitening Products

Topics

Advertisement
UsernamePublicRestriction

Register

PS096762

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel